Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)
Clinical trial NCT02527447 · COMPLETED
Trial details
- NCT number
- NCT02527447
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-08-18
- Primary completion
- 2018-05-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.